期刊文献+

莨菪烷衍生物的合成及其对大鼠气管的拮抗活性和组织选择性 被引量:4

Synthesis of tropane compounds and their antagonistic activity and tissue selectivity to trachea of rats
下载PDF
导出
摘要 目的合成系列莨菪烷衍生物,评价其对大鼠气管的拮抗活性及组织选择性(气管/心脏)。方法以3α-羟基-6β-乙酰氧基莨菪烷(A0)为起始物,通过酰化反应合成系列3α-酰氧基-6β-乙酰氧基莨菪烷。分别选取含丰富M2、M3受体并由其介导收缩的大鼠心脏(M2)和气管平滑肌(M3)为测试样本,通过组织功能实验,测试合成物对大鼠离体心脏和气管的拮抗活性。结果制备8个莨菪烷衍生物,A1~A4对心脏和气管有明显拮抗作用,A5~A8对心脏和气管无拮抗活性。A1对气管的拮抗参数pA2值最大(pA2=7.32),且有较高的组织选择性(气管/心脏)(ΔpA2=1.51)。结论减小莨菪烷母核的C-3α位苯环上取代基的体积或增加苯环上π电子云的密度,对提高化合物拮抗气管的活性及组织选择性(气管/心脏)有利。 Objective To synthesize a series of tropane derivatives,and investigate their antagonistic activity and tissue selectivity(trachea/heart) to trachea of rats. Methods A series of 3α-acyloxy-6β-acetoxy tropanes were prepared by acetylating 3α-hydroxy-6β-acetoxy tropane(A0).The antagonistic activities of compounds to muscarinic M2 and M3 receptors on isolated heart and trachea of rats were tested by functional assays respectively. Results Eight tropane compounds were prepared.A1-A4 elicited obvious antagonistic activity to heart and trachea,while A5-A8 had no muscarinic antagonistic activity to heart and trachea.A1 had the highest antagonistic parameter(pA2=7.32) to trachea and higher tissue selectivity(trachea/heart)(ΔpA2=1.51). Conclusion The antagonistic activity and tissue selectivity(trachea/heart) of compounds to trachea of rats may be improved by decreasing the volume of substituting group connected with phenyl in C-3α position of tropane skeleton or increasing the π-electron density of phenyl ring.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期27-31,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市自然科学基金(10ZR1416900)~~
关键词 莨菪烷 M3受体拮抗剂 离体气管 选择性 tropane muscarinic M3 receptor antagonist isolated trachea selectivity
  • 相关文献

参考文献11

  • 1Fitzgerald MF,Fox JC.Emerging trends in the therapy of COPD:bronchodilators as mono-and combination therapies[J].Drug Discov Today,2007,12(11-12):472-478.
  • 2Gross NJ.Anticholinergic agents in asthma and COPD[J].Eur J Pharmacol,2006,533(1-3):36-39.
  • 3Meacher R,Cordingley J.Respiratory system:applied pharmacology[J].Anaesth Inten Care Med,2005,6(12):419-421.
  • 4Restrepo RD.Use of inhaled anticholinergic agents in obstructive airway disease[J].Respir Care,2007,52 (7):833-851.
  • 5Cazzola M.Aclidinium bromide,a novel long-acting muscarinic M3 antagonist for the treatment of COPD[J].Curr Opin Investig Drugs,2009,10(5):482-490.
  • 6Profits M,Bonanno A,Siena L,et al.Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERKdependent mechanism[J].Eur J Pharmacol,2008,582 (1-3):145-153.
  • 7Wan ZH,Laine DI,Yan HX,et al.Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1] octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD[J].Bioorg Med Chem Lett,2009,19(16):4560-4562.
  • 8Lainé DI,Xie HB,Buffet N,et al.Discovery of novel 8-azoniabicyclo[3.2.1] octane carbamates as muscarinic acetylcholine receptor antagonists[J].Bioorg Med Chem Lett,2007,17(22):6066-6069.
  • 9欧美贤,史一鸣,刘慧中,崔永耀,朱亮,钮因尧,陈红专,陆阳.莨菪烷类化合物的合成及其对M_3受体的拮抗活性[J].上海交通大学学报(医学版),2011,31(7):909-912. 被引量:6
  • 10Vistoli G,Pedretti A,Dei S,et al.Docking analyses on human muscarinic receptors:Unveiling the subtypes peculiarities in agonists binding[J].Bioorg Med Chem,2008,16(6):3049-3058.

二级参考文献11

  • 1杨丽敏,钮因尧,谢一凡,冯菊妹,陈红专,陆阳.3α-磺酰氧(氨)取代的莨菪烷衍生物的合成及其生物活性[J].上海第二医科大学学报,2005,25(3):220-222. 被引量:4
  • 2钮因尧,杨丽敏,崔永耀,朱亮,冯菊妹,陈红专,陆阳.3-取代-6β-乙酰氧基莨菪烷的合成及其生物活性研究[J].化学世界,2005,46(5):299-301. 被引量:3
  • 3Restrepo RD.Use of inhaled anticholinergic agents in obstructiveairway disease. Respiratory Care . 2007
  • 4Durham MC.The effect of tiotropium on exacerbations and airflowinpatients with COPD. Proc (Bayl Univ Med Cent) . 2004
  • 5Cazzola M.Aclidinium bromide,a novel long-acting muscarinic M3antagonist for the treatment of COPD. Current Opinion in Investigational Drugs . 2009
  • 6Vistoli G,Pedretti A,Dei S,et al.Docking analyses on humanmuscarinic receptors:Unveiling the subtypes peculiarities in agonistsbinding. Bioorganic and Medicinal Chemistry . 2008
  • 7Xu R,Sim MK,Go ML.M3/M1-selective antimuscarinic tropinyland piperidinyl esters. Eur J PharmSci . 1999
  • 8Barr RG,Bourbean J,Camargo CA,et al.Tiotropium for stablechronic obstructive pulmonary disease:A meta-analysis. Thorax . 2006
  • 9Dusser D,Bravo ML,Iacono P.The effect of tiontropiumon exacerba-tions and airflowin patient with COPD. European Respiratory Journal . 2006
  • 10Fitzgerald MF,Fox JC.Emerging trends in the therapy of COPD:bronchodilators as mono-and combination therapies〔J〕. Drug Discovery Today . 2007

共引文献5

同被引文献22

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部